Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02SRB
|
||||
Former ID |
DIB011708
|
||||
Drug Name |
BPL-001
|
||||
Synonyms |
HMG CoA reductase inhibitors (cardiovascular disease), Bradford Pharma; HMG CoA reductase inhibitors (cardiovascular disease), Redx Pharma; BPL-001 series (cardiovascular disease), Bradford Pharma; BPL-001 series (cardiovascular disease), Redx Pharma
|
||||
Indication | Cardiovascular disorder [ICD10:I00-I99] | Investigative | [543905] | ||
Company |
Bradford Pharma Ltd
|
||||
Target and Pathway | |||||
Target(s) | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Target Info | Inhibitor | [543905] | |
PANTHER Pathway | Cholesterol biosynthesis | ||||
PathWhiz Pathway | Steroid Biosynthesis | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.